Related Experiment Video
Updated: Jun 23, 2026
08:50
Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
Published on: January 9, 2026
[Molecular methods in thrombophilic states diagnostics].
1Hemato-onkologická klinika Lékarské fakulty UP a FN Olomouc. ludek.slavik@fnol.cz
Vnitrni Lekarstvi
|April 22, 2009
Summary
Molecular genetic testing has advanced thrombophilia diagnostics, identifying key mutations like Factor V Leiden and prothrombin. Future research focuses on understanding the pathophysiology of these conditions rather than solely discovering new genetic markers.
Area of Science:
- Molecular genetics
- Hematology
- Thrombophilia diagnostics
Context:
- Molecular genetic methods for thrombophilia investigation emerged in the 1990s.
- The discovery of activated protein C (APC) resistance's molecular basis in 1994 significantly advanced the field.
- Current methods include PCR-based techniques like restriction fragment length polymorphism, real-time PCR, and allele-specific primers.
Purpose:
- To review the evolution and application of molecular genetic methods in thrombophilia.
- To highlight key genetic markers associated with thrombophilia risk.
- To discuss the ongoing elucidation of the pathophysiology of thrombotic states.
Summary:
- Identified molecular genetic markers for thrombophilia include Factor V Leiden (506R/Q), prothrombin (20210G/A), homozygous MTHFR (677C/T), PAI-1 (4G/5G), and various coagulation inhibitor mutations.
- Polymorphisms like FXIII (Val34Leu) and others have less defined risks.
- Methodological advancements have improved the efficiency of these diagnostic techniques.
Impact:
- Enhanced understanding of the genetic underpinnings of thrombophilia.
- Improved diagnostic accuracy and risk stratification for thrombotic events.
- Shift in research focus towards understanding disease mechanisms over identifying novel, low-risk genetic variants.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:29Modern Molecular Taxonomy
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...